Dongxing Zha

Company: Alloy Therapeutics
Job title: CTO, TCR Discovery & Engineering
Seminars:
The Novel Platform of Discovery and Engineering TCR Mimic Antibodies to Enhance Therapeutic Index of Efficacy and Safety 11:30 am
• Examining methods to engineer TCR mimic antibodies to magnify specificity for target antigens • Reviewing the pros and cons of affinity enhanced TCR mimic antibodies to safeguard patient safety • Escalating affinity to the target peptide as well as the MHC to optimize efficacyRead more
day: Day Two